Click Here to View
The 2018 NCPA Digest revealed that 92% of revenue for independents comes from prescription drugs, but margins are hampered by low reimbursement rates.
The 10-year trends show that, since the Medicare Part D prescription drug benefit was introduced, pharmacists’ gross margins have declined steadily. In 2017, 36% of prescriptions in independents were covered by Medicare Part D, and 17% by Medicaid; more than half of independent volumes are now paid by a government program. Most of the Affordable Care Act came into effect during this time as well.
Pharmacists have cut payroll to help fill in the lost revenue, but it isn’t enough.
FDA’s Recent Exemptions: What Do They Mean as We Finalize DSCSA Implementation?
October 31st 2024Kala Shankle, Vice President of Regulatory Affairs with the Healthcare Distribution Alliance, and Ilisa Bernstein, President of Bernstein Rx Solutions, LLC, discussed recent developments regarding the Drug Supply Chain Security Act.
Examining Impact of COVID-19 Diagnosis Timing on AF Progression | AHA 2024
November 21st 2024“[O]ur data do not support the hypothesis that early COVID resulted in more significant structural or electrical cardiac remodeling that would increase the likelihood of atrial fibrillation progression,” the authors said.